- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 09.04. | CDMO PharmaLogic takes majority stake in Norway's Agilera to boost global radiopharma footprint | ||
| 09.04. | Annexon rolls out Guillain-Barré awareness campaign for HCPs amid promising results for targeted therapy | ||
| 09.04. | Mucinex maker Reckitt lets go of 190 staffers in NJ while Organon lays off 93 amid restructuring efforts | ||
| 09.04. | BMS prevails in antitrust lawsuit over its defense of multiple myeloma blockbuster Pomalyst | ||
| 09.04. | Pharma stocks slip as Trump renews threats of 'major' pharmaceutical tariff | ||
| 09.04. | DHL earmarks €2B to enhance biopharma cold chain operations as demand grows | ||
| 08.04. | Rocket boosts preparations for gene therapy launch with new commercial chief from J&J, AstraZeneca | ||
| 08.04. | RFK Jr. promotes measles vaccine as Texas outbreak continues | ||
| 08.04. | As Trump threatens tariffs on drugs, industry warns EU of $100B-plus pharma exodus to US | ||
| 08.04. | Novo Nordisk plugs more than $1B into upgrade of Brazilian manufacturing operations for injectable drugs, including GLP-1s | ||
| 07.04. | In Bay Area, Gilead cuts 149 positions and Roche's diagnostics division lays off 108 | ||
| 07.04. | CAR-T developer Lyell lays off 73 ImmPact staffers, shutters LA facility shortly after acquisition | ||
| 07.04. | Novo's Wegovy, J&J's Tremfya step up TV ad spending amid March Madness tournament | ||
| 07.04. | Viatris agrees to pay up to $335M to settle opioid claims | ||
| 07.04. | CDMO AmplifyBio closes doors amid tough market for early-stage cell and gene therapy development | ||
| 07.04. | Rhythm eyes label expansion after Imcivree helps patients with brain damage-related obesity lose weight | ||
| 07.04. | Art Garfunkel joins Sun Pharma to share how psoriasis drug Ilumya provided bridge over troubled water | ||
| 04.04. | 'SNL' star Kenan Thompson serves up a new campaign for Phathom's Voquezna | ||
| 04.04. | Amgen wins key rare disease nod for Uplizna, checking off one goal in expansion push | ||
| 04.04. | FDA staff cuts could disrupt drug reviews, putting agency's critical funding programs at risk: reports | ||
| 04.04. | Eli Lilly CEO on Trump's tariffs: 'It'll be hard to come back from here' | ||
| 04.04. | GSK, Pfizer resolve RSV patent feud amid vaccine market uncertainty | ||
| 04.04. | Fierce Pharma Asia-Pharma CEOs meet Xi Jinping; Trump's tariffs; BioNTech's bispecific data | ||
| 03.04. | Amid FDA tumult, agency misses decision deadline on Novavax's COVID shot | ||
| 03.04. | Novo's commercial strategy head hits the exit, prompting a slew of executive team shakeups |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
